Search

everythinglearnresearchcommunity

for

Search:↓

Stem cells slowed lung tumor growth but increased colon tumor growth in mice.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

3D bioprinted lung cancer models in a mouse-like structure offer a better way to study radiation effects without using live animals.

GCN reduces lung inflammation and damage from air pollution in mice.

Minoxidil can cause lung disease that looks like hypersensitivity pneumonitis.

Aumolertinib effectively controls lung cancer and improves quality of life.

EGFR inhibitors for lung cancer can cause severe skin issues.

Extracellular vesicles from amniotic fluid stem cells can improve underdeveloped fetal lungs.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

Fluconazole is the preferred treatment for deep skin infections in immunocompromised patients.

The new drug delivery system effectively targets lung cancer cells.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

A gene-based model predicts lung adenocarcinoma outcomes and helps guide treatment decisions.

Patients with non-small-cell lung cancer need significant survival gains to accept severe side effects.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Chitosan-encapsulated Cordyceps militaris reduces lung cell damage from pollution.

Inhaling medicine may reduce side effects and improve treatment for a major lung cancer type.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

Erlotinib can cause excessive eyelash growth.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Metabolic syndrome may increase the risk of small cell lung cancer.

Flubendazole in a nanoemulsion can potentially treat lung cancer and cryptococcal meningitis effectively and safely.

Severe COVID-19 may increase lung cancer risk and affect treatment in women due to hormonal changes.